Improved health care resource utilization following video-EEG-confirmed diagnosis of nonepileptic psychogenic seizures.

PubWeight™: 1.16‹?› | Rank: Top 10%

🔗 View Article (PMID 9808114)

Published in Seizure on October 01, 1998

Authors

R C Martin1, F G Gilliam, M Kilgore, E Faught, R Kuzniecky

Author Affiliations

1: Epilepsy Center, Department of Neurology, University of Alabama at Birmingham, School of Medicine, 35294-0021, USA.

Associated clinical trials:

Evaluation of a Telephone Follow-up Procedure on the Quality of Life in Psychogenic Non-epileptic Seizures (EDUQ-CPNE) | NCT02311829

Articles citing this

The safety of antiepileptic drug withdrawal in patients with non-epileptic seizures. J Neurol Neurosurg Psychiatry (2005) 1.52

Tilt-induced vasovagal syncope and psychogenic pseudosyncope: Overlapping clinical entities. Neurology (2015) 1.50

Psychogenic nonepileptic seizures: a treatment review. What have we learned since the beginning of the millennium? Neuropsychiatr Dis Treat (2012) 1.12

Nonepileptic seizures treatment workshop summary. Epilepsy Behav (2006) 1.02

The approach to patients with "non-epileptic seizures". Postgrad Med J (2005) 0.95

How to Use Your Clinical Judgment to Screen for and Diagnose Psychogenic Nonepileptic Seizures without Video Electroencephalogram. Innov Clin Neurosci (2011) 0.87

How to avoid a misdiagnosis in patients presenting with transient loss of consciousness. Postgrad Med J (2006) 0.82

Resetting of brain dynamics: epileptic versus psychogenic nonepileptic seizures. Epilepsy Behav (2011) 0.78

Long-term video EEG monitoring for diagnosis of psychogenic nonepileptic seizures. Neuropsychiatr Dis Treat (2014) 0.75

Health related quality of life in patients admitted for video-electroencephalography monitoring diagnosed with epilepsy or psychogenic non-epileptic seizures. Neurosciences (Riyadh) (2016) 0.75

Dissociative seizures: a challenge for neurologists and psychotherapists. Dtsch Arztebl Int (2013) 0.75

COgnitive behavioural therapy vs standardised medical care for adults with Dissociative non-Epileptic Seizures (CODES): a multicentre randomised controlled trial protocol. BMC Neurol (2015) 0.75

Number of patient-reported allergies helps distinguish epilepsy from psychogenic nonepileptic seizures. Epilepsy Behav (2016) 0.75

The diagnostic and therapeutic challenge of nonepileptic seizures: An interdisciplinary approach. Epilepsy Behav Case Rep (2014) 0.75

Health care utilization and poor reassurance: potential predictors of somatoform disorders. Psychiatr Clin North Am (2011) 0.75

What Are We Communicating When We Present the Diagnosis of PNES? Epilepsy Curr (2015) 0.75

Articles by these authors

A comparison of four treatments for generalized convulsive status epilepticus. Veterans Affairs Status Epilepticus Cooperative Study Group. N Engl J Med (1998) 4.31

Cognitive effects of topiramate, gabapentin, and lamotrigine in healthy young adults. Neurology (1999) 2.72

Oxcarbazepine: double-blind, randomized, placebo-control, monotherapy trial for partial seizures. Neurology (1999) 2.61

Congenital porencephaly: MR features and relationship to hippocampal sclerosis. AJNR Am J Neuroradiol (1998) 2.08

Practice advisory: The use of felbamate in the treatment of patients with intractable epilepsy: report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Neurology (1999) 2.07

Placebo-controlled study of the efficacy and safety of lamotrigine in patients with partial seizures. U.S. Lamotrigine Protocol 0.5 Clinical Trial Group. Neurology (1993) 1.90

Racial disparities in the use of surgical treatment for intractable temporal lobe epilepsy. Neurology (2005) 1.81

Mutations in the X-linked filamin 1 gene cause periventricular nodular heterotopia in males as well as in females. Hum Mol Genet (2001) 1.80

Patient-oriented outcome assessment after temporal lobectomy for refractory epilepsy. Neurology (1999) 1.80

Peer discussion on training physicians to be competent communicators: support for a multiple discourse approach. South Med J (1997) 1.73

Bilateral parasagittal parietooccipital polymicrogyria and epilepsy. Ann Neurol (1997) 1.72

Intrinsic epileptogenesis of hypothalamic hamartomas in gelastic epilepsy. Ann Neurol (1997) 1.71

Efficacy of rapid IV administration of valproic acid for status epilepticus. Neurology (2005) 1.55

Significance of interictal temporal lobe delta activity for localization of the primary epileptogenic region. Neurology (1999) 1.49

Evaluating functional MRI procedures for assessing hemispheric language dominance in neurosurgical patients. Neuroradiology (2005) 1.49

Cognitive consequences of coexisting temporal lobe developmental malformations and hippocampal sclerosis. Neurology (1999) 1.48

Cerebral complications of angiography for transient ischemia and stroke: prediction of risk. Neurology (1979) 1.47

Characterization of mutations in the gene doublecortin in patients with double cortex syndrome. Ann Neurol (1999) 1.47

Ifosfamide causes a diazepam-sensitive encephalopathy. Neurology (1993) 1.44

Patient-validated content of epilepsy-specific quality-of-life measurement. Epilepsia (1997) 1.41

Cortical abnormalities in epilepsy revealed by local EEG synchrony. Neuroimage (2007) 1.37

Bilateral porencephalic defect and bilateral perisylvian polymicrogyria. Brain Dev (1991) 1.37

Hippocampal sclerosis in temporal lobe epilepsy demonstrated by magnetic resonance imaging. Ann Neurol (1991) 1.34

Acute psychotic symptoms induced by topiramate. Seizure (1999) 1.34

Normalization of contralateral metabolic function following temporal lobectomy demonstrated by 1H magnetic resonance spectroscopic imaging. Ann Neurol (1996) 1.27

Occurrence of seizure clusters and status epilepticus during inpatient video-EEG monitoring. Neurology (2003) 1.19

Weight loss associated with vagus nerve stimulation. Neurology (2002) 1.14

Familial perisylvian polymicrogyria: a new familial syndrome of cortical maldevelopment. Ann Neurol (2000) 1.13

Modulation of cerebral GABA by topiramate, lamotrigine, and gabapentin in healthy adults. Neurology (2002) 1.12

Relative utility of 1H spectroscopic imaging and hippocampal volumetry in the lateralization of mesial temporal lobe epilepsy. Neurology (1998) 1.11

Magnetic resonance spectroscopic imaging in temporal lobe epilepsy: neuronal dysfunction or cell loss? Arch Neurol (2001) 1.11

Magnetic resonance imaging in childhood intractable partial epilepsies: pathologic correlations. Neurology (1993) 1.09

Postmarketing experience with topiramate and cognition. Epilepsia (2001) 1.08

Predictive value of magnetic resonance imaging in temporal lobe epilepsy surgery. Arch Neurol (1993) 1.06

Subjective versus objective memory change after temporal lobe epilepsy surgery. Neurology (1999) 1.06

Proton nuclear magnetic resonance spectroscopic imaging of human temporal lobe epilepsy at 4.1 T. Ann Neurol (1995) 1.06

Epilepsy surgery outcome: comprehensive assessment in children. Neurology (1997) 1.05

Visual confrontation naming and hippocampal function: A neural network study using quantitative (1)H magnetic resonance spectroscopy. Brain (2000) 1.05

Adverse antiepileptic drug effects in new-onset seizures: a case-control study. Neurology (2011) 1.04

The safety of rapid valproic acid infusion. Epilepsia (2000) 1.04

Adult myoclonic epilepsy: a distinct syndrome of idiopathic generalized epilepsy. Neurology (2000) 1.04

Cortical dysplasia in temporal lobe epilepsy: magnetic resonance imaging correlations. Ann Neurol (1991) 1.04

Topiramate increases cerebral GABA in healthy humans. Neurology (1998) 0.99

Cognitive and behavioral effects of antiepileptic drugs. Epilepsy Behav (2001) 0.97

Proton spectroscopic imaging at 4.1 tesla in patients with malformations of cortical development and epilepsy. Neurology (1997) 0.97

Wisconsin Card Sorting performance in patients with temporal lobe epilepsy: clinical and neuroanatomical correlates. Epilepsia (2000) 0.96

Multimodality MRI in mesial temporal sclerosis: relative sensitivity and specificity. Neurology (1997) 0.96

Predictive value of 1H MRSI for outcome in temporal lobectomy. Neurology (1999) 0.96

Late-onset variant of Huntington's chorea. South Med J (1983) 0.95

Frequency of epilepsy in patients with psychogenic seizures monitored by video-EEG. Neurology (2003) 0.95

Individual memory change after anterior temporal lobectomy: a base rate analysis using regression-based outcome methodology. Epilepsia (1998) 0.94

Quantitative MRI in temporal lobe epilepsy: evidence for fornix atrophy. Neurology (1999) 0.94

Vagus nerve stimulation for treatment of partial seizures: 3. Long-term follow-up on first 67 patients exiting a controlled study. First International Vagus Nerve Stimulation Study Group. Epilepsia (1994) 0.93

Temporal lobe developmental malformations and epilepsy: dual pathology and bilateral hippocampal abnormalities. Neurology (1998) 0.92

Recurrent mutations in DNAJC5 cause autosomal dominant Kufs disease. Clin Genet (2012) 0.92

Is the intracellular pH different from normal in the epileptic focus of patients with temporal lobe epilepsy? A 31P NMR study. Neurology (1996) 0.92

Ambulatory EEG monitoring. J Clin Neurophysiol (1999) 0.91

Estrogen regulation of adipose tissue lipoprotein lipase--possible mechanism of body fat distribution. Am J Obstet Gynecol (1998) 0.91

Altered brain sodium channel transcript levels in human epilepsy. Brain Res Mol Brain Res (1996) 0.91

Familial myopathy with changes resembling inclusion body myositis and periventricular leucoencephalopathy. A new syndrome. Brain (1988) 0.90

Brainstem auditory evoked responses in brainstem infarction. Stroke (1985) 0.90

Bilateral hippocampal atrophy: consequences to verbal memory following temporal lobectomy. Neurology (2001) 0.89

Metabolic networks in epilepsy by MR spectroscopic imaging. Acta Neurol Scand (2012) 0.88

MRI extrahippocampal volumes and visual memory: correlations independent of MRI hippocampal volumes in temporal lobe epilepsy patients. J Int Neuropsychol Soc (1999) 0.86

Comparative cognitive effects of carbamazepine and gabapentin in healthy senior adults. Epilepsia (2001) 0.86

Occipitoparietal epilepsy, hippocampal atrophy, and congenital developmental abnormalities. Epilepsia (2000) 0.86

Cognitive correlates of 1H MRSI-detected hippocampal abnormalities in temporal lobe epilepsy. Neurology (1999) 0.86

Self-induced photosensitive absence seizures with ictal pleasure. Arch Neurol (1986) 0.85

Temporal lobe developmental malformations and hippocampal sclerosis: epilepsy surgical outcome. Neurology (1999) 0.85

Physical exercise, stressful life experience, and depression in adults with epilepsy. Epilepsia (1995) 0.85

Chronic temporal lobe epilepsy: spatial extent and degree of metabolic dysfunction studied with magnetic resonance spectroscopy (MRS). Epilepsy Res (2004) 0.84

Supplementary sensorimotor area epilepsy. Seizure localization, cortical propagation and subcortical activation pathways using ictal SPECT. Brain (1997) 0.84

Association of combined MRI, interictal EEG, and ictal EEG results with outcome and pathology after temporal lobectomy. Epilepsia (1997) 0.84

Low intensity vagal nerve stimulation lowers human thermal pain thresholds. Pain (2000) 0.84

Occipital lobe developmental malformations and epilepsy: clinical spectrum, treatment, and outcome. Epilepsia (1997) 0.83

Homocysteine, folate, vitamin B-12 and vitamin B-6 in patients receiving antiepileptic drug monotherapy. Epilepsy Res (2000) 0.83

Congenital porencephaly and hippocampal sclerosis. Clinical features and epileptic spectrum. Neurology (1997) 0.83